PHOENIX, July 18, 2017 (GLOBE NEWSWIRE) — Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) announced today that Andrew G. Long has joined the company as Chief Financial Officer, effective August 7, 2017.
Category Archives: AZBio News
Castle Biosciences’ Uveal Melanoma Test Receives Positive Medicare Local Coverage Determination and Commercial Insurance Positive Coverage Policies
Over 115 million lives now covered: Palmetto GBA issues final local coverage determination; Fourteen Blue Cross Blue Shield plans and Aetna release positive coverage policy
Dr. Edgar Staren Appointed President of TransMed7
TransMed7, LLC Announces President Appointment
ASU-TGen led study identifies source of mutation in Alzheimer’s disease
ANK1 gene expression change found in brain’s microglia cells associated with neuroinflammationContinue reading
SenesTech’s ContraPest Effective in a Second Species of Rat
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced the effective application of ContraPest in a second species of rat; Rattus rattus, commonly known as the black rat or roof rat.
DxNA LLC Announces 510(K) Submission of the GeneSTAT® Analyzer and GeneSTAT® Coccidioides Assay
Precision test backed by expertise of Valley Fever Center for Excellence; incorporates technology developed by TGenContinue reading
University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center Opens Multidisciplinary Thoracic Clinic
Advancing its commitment to patient-centered care, the University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center recently launched a multidisciplinary thoracic clinic.Continue reading
Stand Up To Cancer and PBS LearningMedia program allows student to search for answers at TGen
2017 Emperor Science Award gives Arizona high school student opportunity to investigate pancreatic cancer by studying zebrafishContinue reading